DISCOUNT OPTIONSSCHEIN - NOVO NORDISK ADR B | Market Closed - Deutsche Boerse AG 14:02:02 2024-06-28 EDT | ||
| 0.092 EUR | 0.00% |
|
| Current month | -58.18% | ||
| 1 month | -59.65% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
NOVO NORDISK A/S
Latest news about NOVO NORDISK A/S
More news
| Date | Price | Change |
|---|---|---|
| 24-06-28 | 0.092 | 0.00% |
| 24-06-27 | 0.092 | -2.13% |
| 24-06-26 | 0.094 | +14.63% |
| 24-06-25 | 0.082 | -21.15% |
| 24-06-24 | 0.104 | -5.45% |
Delayed Quote Deutsche Boerse AG
Last update June 28, 2024 at 02:02 pm
More quotesStatic data
| Product type | Produits Exotiques |
|---|---|
| Buy / Sell | PUT |
| Underlying | NOVO NORDISK A/S |
| Issuer | 
Vontobel
|
| WKN | VM37QE |
| ISIN | DE000VM37QE6 |
| Date issued | 2023-10-19 |
| Strike | 120 $ |
| Maturity | 2024-09-20 (83 Days) |
| Parity | 10 : 1 |
| Emission price | 1.07 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.33 € |
|---|---|
| Lowest since issue | 0.076 € |
| Spread | 0.01 € |
| Spread % | 9.43% |
Company Profile
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- diabetes and obesity treatment products (92.6%);
- rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc.
Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
Consensus: Novo Nordisk A/S
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
1,006
DKK
Average target price
949.7
DKK
Spread / Average Target
-5.56%
- Stock Market
- Certificates
- Certificat
